33 Development of a clinical ex vivo assay for the assessment of therapeutic CD28 costimulatory pathway engagement
| Main Authors: | , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2021-11-01
|
| Series: | Journal for ImmunoTherapy of Cancer |
| _version_ | 1819102420600356864 |
|---|---|
| author | Jing Yang Gary Means Pamela Holland Chelsea Gudgeon Mark Maurer Sherri Mudri Lori Blanchfield Stacey Dillon Zelanna Goldberg Stanford Peng |
| author_facet | Jing Yang Gary Means Pamela Holland Chelsea Gudgeon Mark Maurer Sherri Mudri Lori Blanchfield Stacey Dillon Zelanna Goldberg Stanford Peng |
| author_sort | Jing Yang |
| collection | DOAJ |
| first_indexed | 2024-12-22T01:34:17Z |
| format | Article |
| id | doaj.art-c8021284446649e989e2921b9cb13fd1 |
| institution | Directory Open Access Journal |
| issn | 2051-1426 |
| language | English |
| last_indexed | 2024-12-22T01:34:17Z |
| publishDate | 2021-11-01 |
| publisher | BMJ Publishing Group |
| record_format | Article |
| series | Journal for ImmunoTherapy of Cancer |
| spelling | doaj.art-c8021284446649e989e2921b9cb13fd12022-12-21T18:43:26ZengBMJ Publishing GroupJournal for ImmunoTherapy of Cancer2051-14262021-11-019Suppl 210.1136/jitc-2021-SITC2021.03333 Development of a clinical ex vivo assay for the assessment of therapeutic CD28 costimulatory pathway engagementJing Yang0Gary Means1Pamela Holland2Chelsea Gudgeon3Mark Maurer4Sherri Mudri5Lori Blanchfield6Stacey Dillon7Zelanna Goldberg8Stanford Peng9Department of Neurology, Laboratory of Neurodegenerative Disorders, Rare disease center, West China Hospital, Sichuan University, Chengdu, ChinaAff510 grid.438014.aSeattle Genetics, Inc. Bothell WA USA3Surface Oncology, Inc., Cambridge, MA, USAAlpine Immune Sciences, Inc., Seattle, WA, USAAlpine Immune Sciences, Inc., Seattle, WA, USAAlpine Immune Sciences, Inc., Seattle, WA, USAAlpine Immune Sciences, Inc., Seattle, WA, USAAlpine Immune Sciences, Inc., Seattle, WA, USAAlpine Immune Sciences, Inc., Seattle, WA, USAAlpine Immune Sciences, Inc., Seattle, WA, USA |
| spellingShingle | Jing Yang Gary Means Pamela Holland Chelsea Gudgeon Mark Maurer Sherri Mudri Lori Blanchfield Stacey Dillon Zelanna Goldberg Stanford Peng 33 Development of a clinical ex vivo assay for the assessment of therapeutic CD28 costimulatory pathway engagement Journal for ImmunoTherapy of Cancer |
| title | 33 Development of a clinical ex vivo assay for the assessment of therapeutic CD28 costimulatory pathway engagement |
| title_full | 33 Development of a clinical ex vivo assay for the assessment of therapeutic CD28 costimulatory pathway engagement |
| title_fullStr | 33 Development of a clinical ex vivo assay for the assessment of therapeutic CD28 costimulatory pathway engagement |
| title_full_unstemmed | 33 Development of a clinical ex vivo assay for the assessment of therapeutic CD28 costimulatory pathway engagement |
| title_short | 33 Development of a clinical ex vivo assay for the assessment of therapeutic CD28 costimulatory pathway engagement |
| title_sort | 33 development of a clinical ex vivo assay for the assessment of therapeutic cd28 costimulatory pathway engagement |
| work_keys_str_mv | AT jingyang 33developmentofaclinicalexvivoassayfortheassessmentoftherapeuticcd28costimulatorypathwayengagement AT garymeans 33developmentofaclinicalexvivoassayfortheassessmentoftherapeuticcd28costimulatorypathwayengagement AT pamelaholland 33developmentofaclinicalexvivoassayfortheassessmentoftherapeuticcd28costimulatorypathwayengagement AT chelseagudgeon 33developmentofaclinicalexvivoassayfortheassessmentoftherapeuticcd28costimulatorypathwayengagement AT markmaurer 33developmentofaclinicalexvivoassayfortheassessmentoftherapeuticcd28costimulatorypathwayengagement AT sherrimudri 33developmentofaclinicalexvivoassayfortheassessmentoftherapeuticcd28costimulatorypathwayengagement AT loriblanchfield 33developmentofaclinicalexvivoassayfortheassessmentoftherapeuticcd28costimulatorypathwayengagement AT staceydillon 33developmentofaclinicalexvivoassayfortheassessmentoftherapeuticcd28costimulatorypathwayengagement AT zelannagoldberg 33developmentofaclinicalexvivoassayfortheassessmentoftherapeuticcd28costimulatorypathwayengagement AT stanfordpeng 33developmentofaclinicalexvivoassayfortheassessmentoftherapeuticcd28costimulatorypathwayengagement |